In case you missed it! Following the addition of StemSight - Vision Unlimited to our family of licensees earlier this year, our CEO, John E. Milad, and StemSight’s CCO, Ross Macdonald, discuss how #CRISPRCas9 has become a transformative tool in life sciences. If you haven’t already, read our latest article in European Biopharmaceutical Review (EBR): https://shorturl.at/0dgFD
ERS Genomics’ Post
More Relevant Posts
-
Read our article in the European Biopharmaceutical Review (EBR) to learn more about how Just - Evotec Biologics is bringing #continuousbiomanufacturing to Europe.
Continuous biomanufacturing arrives in Europe! We’re thrilled to announce that Just - Evotec Biologics, a pioneer in #ContinuousBiomanufacturing, is on track to launch its state-of-the-art J.POD® Toulouse facility this September! This expansion marks a significant milestone in biomanufacturing innovation, bringing cutting-edge technology and increased production capabilities to the European biopharmaceutical landscape. Stay tuned for more updates and read about our groundbreaking facility in the latest issue of the European Biopharmaceutical Review: https://hubs.ly/Q02CpN_T0 #Biomanufacturing #Innovation #Biopharma #JustEvotecBiologics
-
-
Ligand’s Captisol technology platform has helped optimize the solubility and stability of drugs for some of the world’s leading biopharmaceutical companies including Merck Pfizer Amgen and Gilead Sciences. Today there are more than 15 Captisol-enabled™ products approved worldwide. The leaders of our Captisol team, Drs. Vince Antle and James Pipkin, recently sat down with Lawrence Business Magazine to discuss how this unique technology has changed how drugs are developed and formulated. Read the article here: https://bit.ly/4bRjJtv
-
-
In case you missed it, the webinar 'Chain reaction: Navigating stability challenges in the Biopharmaceutical supply chain - from sourcing to shipping' is now available on demand 👉 https://lnkd.in/e_S4Wss Thank you to Q1 Scientific Ltd. for including us in this engaging discussion of how supply chain stakeholders can collaboratively address biopharmaceutical stability challenges.
Thank you to our panellists today for participating in our live webinar on 'Chain reaction: Navigating stability challenges in the Biopharmaceutical supply chain – from sourcing to shipping'. Moderated by Stephen Delaney, Managing Director at Q1 Scientific, our panel of experts including Aideen Glynn, Quality Manager at Q1 Scientific, Teresa C., Functional Lead, Supply Chain at APC & VLE Therapeutics, and Andrew Moss, Customer Solutions & Implementation Manager UK at Biocair delved into the intricate world of biopharmaceutical stability. Missed the live session? No worries! You can watch the recording and explore all our previous webinars on our website: https://lnkd.in/e_S4Wss #Biopharmaceutical #SupplyChain #StabilityStorage #Logistics
-
-
Here is another one of my favorite quotes from an attendee of Mass Spec: "Very informative and interesting. Excellent format for learning." Join us at the CASSS Symposium on the Practical Applications of Mass Spectrometry. You'll be writing the same thing after the symposium!
"It is an excellent conference that is well-organized and gives you relevant knowledge about what is going on in the biopharmaceutical industry worldwide." -Sarolta Baginé Timári, Past Attendee Don't miss this year's Mass Spec Symposium where we will focus on best practices and innovative approaches for mass spectrometry applications in the discovery, development, and commercialization of biopharmaceuticals. Register by August 27. #casss #MassSpec2024 #MassSpectrometry #MassSpec #biopharmaceuticals
-
-
a new macrocycle and covalent KRAS G12C inhibitor. From the abstract ...We leveraged structure-based drug design to identify a macrocyclic core structure, and hypothesis-driven optimization of biopharmaceutical properties to further improve metabolic stability and tolerability. https://lnkd.in/dc_UgND9
-
Have you listened to Episode 6 of the GxPodcast yet? 🎙️ Here's our team discussing biopharmaceutical careers with Eckart W Schwarz, MD and the incredible careers that unfold in this industry. Want to hear more? Tune in here: 🔗 https://lnkd.in/eXGNTsKM #GxPodcast #biopharmaceuticalcareers
-
Global Forecast 2022-2035 Report delves into the T-cell therapy market, spotlighting stakeholders' endeavors in this dynamic biopharmaceutical sector. It offers a comprehensive analysis of the current market dynamics and future prospects, providing valuable insights for investors, researchers, and industry players navigating the evolving landscape of immunotherapy.
-
-
Optimisation of workflows is what we do at Genovis - this is yet another example - now with a RNAase inhibitor in collaboration with SEQURNA AB #genovis #RNAaseinhibitor
🌟 We are proud to announce that we today complete a strategic investment in SEQURNA AB, a developer of next-generation RNase inhibitors! 🌟 This strategic investment opens up for new product offerings to both existing and new customers, and facilitates the expansion into new application areas. We will utilize our distribution network to market and sell SEQURNA’s RNase inhibitors alongside our own catalogue of innovative tools for the biopharmaceutical and research industries! We look forward to continuing developing optimized workflows using Smart, efficient and reliable tools, and we are excited to add SEQURNA’s next-generation RNase inhibitors to our product portfolio! 🤩 Link to the press release: https://lnkd.in/d__Hste5 #genovis #news
-
-
In our new video, Dr. Robert Popovian busts three myths about so-called march-in rights and explains why the government should instead be encouraging companies to continue investing billions in biopharmaceutical innovation. Watch the full clip here: https://lnkd.in/e4TxHgXf
-
-
In this exclusive guidebook, discover the journey of a molecule & how it's built to serve. Merck experts share key considerations for biopharmaceutical companies as they advance their antibody drug to commercial manufacturing, plus more. Don't miss out! Learn More>> https://hubs.li/Q02NRXZg0 Sponsored by Merck
-
